Drug policy in Belarus, Kazakhstan, Kyrgyzstan and Russia: presentation of the study by The Economist

On March 10, 2021, from 10 AM to 1 PM ET (EET, UTC +2), an online discussion will be held on the first regional study “Drug Policy in EECA: the Economic, Health and Social Impact” conducted by the Economist Intelligence Unit with the support of the Alliance for Public Health in 2020.

The research is unique as it provides data on the economic consequences of the existing drug policy on the example of Belarus, Kazakhstan, Kyrgyzstan and Russia, demonstrating financial costs that countries incur by continuing the existing approach and practices. The document also contains forecasts of what changes await for the states in case they change approaches to drug policy. This is the first study of its kind in Eastern Europe and Central Asia (EECA).

The main purpose of the online presentation on March 10 is to present and discuss the findings from the survey, as well as to initiate wider stakeholder dialogue in focus countries.

The program of the event will be published here on March 4, 2021. To participate in the event, you must pre-register: https://bit.ly/381dmWC. Before the event, all registered participants will be sent a ZOOM link to join the online conference.

The language of the event is Russian and English with simultaneous translation.